All Stories

  1. Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy

    Article • PLOS One, May 2021, PLOS

    JOAN BRUGGE

  2. Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways

    Article • Proceedings of the National Academy of Sciences, June 2020, Proceedings of the National Academy of Sciences

    JOAN BRUGGE, Ioannis Zervantonakis

  3. Mapping the dynamics of force transduction at cell–cell junctions of epithelial clusters

    Article • eLife, December 2014, eLife

    JOAN BRUGGE